Tumormarker

Human VEGF-165 Antibody(3A6); 1mg

Human VEGF-165 Antibody(3A6); 500ug

Human VEGF-165 Antibody(3A6); 50ug

Recombinant Human TRAIL; 1mg

Recombinant Human TRAIL; 500ug

Recombinant Human VEGF165; 500ug

Recombinant Human VEGF165; 50ug

Recombinant Human MMP-1; 500ug

Recombinant Human MMP-1; 50ug

Recombinant Human KNG1; 500ug

Recombinant Human SPP1; 50ug

Recombinant Human HE4; 50ug

Recombinant Human Lactotransferrin; 1mg

Recombinant Human Lactotransferrin; 50ug

Recombinant Human GOLM1; 500ug

Recombinant Human GOLM1; 50ug

Recombinant Human IGFBP-5; 50ug

Recombinant Human SCF; 500ug

Recombinant Human ER alpha; 1mg

Recombinant Human ER alpha; 500ug

Recombinant Human ER alpha; 50ug

Recombinant Human CEA; 1mg

Recombinant Human CEA; 500ug

Recombinant Human CEA; 50ug

Recombinant Human HER2; 1mg

Recombinant Human HER2; 50ug

Recombinant Human NSE; 1mg

Recombinant Human NSE; 500ug

Recombinant Human NSE; 50ug

Recombinant Human CYFRA21-1; 1mg

Recombinant Human MUC-1; 50ug

Recombinant Human PG?; 1mg

Human VEGF-165 Antibody (12E3); 1mg

Human VEGF-165 Antibody (12E3); 50ug

Human VEGF-165 Antibody (10F9); 1mg

Recombinant Human FGFb; 500ug

Recombinant Human Leptin; 500ug

Recombinant Human VEGF165; 1mg

Recombinant Human TNF beta; 500ug

Recombinant Human TNF beta; 50ug

Recombinant Human MMP-1; 1mg

Recombinant Human Vitronectin; 1mg

Recombinant Human Serpin E1; 1mg

Recombinant Human Serpin E1; 500ug

Recombinant Human SPP1; 1mg

Recombinant Human HE4; 500ug

Recombinant Human Lactotransferrin; 500ug

Recombinant Human GOLM1; 1mg